cui1,cui2,relation,name1,name2,type1,type2,weight,predicate
C0001367,C4321237,NEG_AFFECTS,Acyclovir,High Level,phsu,fndg,1,NEG_AFFECTS_PHSUnafctFNDG
C0003402,C0750558,NEG_AFFECTS,Antioxidants,Unlikely,phsu,fndg,1,NEG_AFFECTS_PHSUnafctFNDG
C0014695,C0349790,NEG_AFFECTS,Ergocalciferol,Exacerbation of asthma,phsu,fndg,1,NEG_AFFECTS_PHSUnafctFNDG
C1136254,C0554101,NEG_AFFECTS,Microbicides,Villous atrophy,phsu,fndg,1,NEG_AFFECTS_PHSUnafctFNDG
C1136254,C3843353,NEG_AFFECTS,Microbicides,Very Difficult,phsu,fndg,1,NEG_AFFECTS_PHSUnafctFNDG
C1827106,C0458247,NEG_AFFECTS,Dipeptidyl-Peptidase IV Inhibitors,Allodynia,phsu,fndg,1,NEG_AFFECTS_PHSUnafctFNDG
C4305807,C3816499,NEG_AFFECTS,LC16M8,Pathogenic,phsu,fndg,1,NEG_AFFECTS_PHSUnafctFNDG
